Three Years Later, Foley Survey Reveals Positive Prognosis for Telemedicine


When we launched the 1945-19002 Inaugural Survey of Foley It was clear that health care leaders were not ready to make telemedicine an important focus of their business strategies and their patients. The interest was there but despite tremendous technological advances and imaginative applications, most of the telemedicine programs were in the early stages and there was little acceptance by all of the health care community.

The shift to the present time and the industry's prospects have changed dramatically, largely thanks to proven patient outcomes and a growing demand from suppliers seeking to improve the quality of care in a more practical and cost-effective way.

According to our survey 2017 where we interviewed a range of executives in hospitals, specialty clinics, ancillary services and related organizations, three-quarters of respondents currently offer, or plan to provide, telemedicine services. Now, compare that to three years ago, when nearly 87% of them did not expect their patients to use telemedicine services at that time – that 's right. is a reversal.

Beyond adoption, providers said they were very satisfied with the telemedicine platforms that they used. More than half of the organizations that perform the return on investment reported savings of 10% or more. And, one third of respondents said that 50 percent or more of patients continued to use telemedicine after a first visit, demonstrating increasing patient satisfaction with the service.

The flood of telemedicine programs entering the phases of maturity and implementation is not without complications, however. Providers are already looking to expand their telemedicine programs overseas, where they will encounter unfamiliar governance in foreign jurisdictions. In addition, there is still work to be done in the United States, where the Food and Drug Administration must weigh on new software and other digital health technologies, and state and federal governments must reduce ambiguities and regulatory barriers.

These complex problems can and should be considered as great opportunities for the major players in the health care industry. Those who are able to navigate existing and new laws and regulations will be better positioned to take advantage of rapid advances in technology that, in turn, will enable them to provide innovative patient care in new markets around the world.

To learn more about these key themes and others that have emerged in our research, please visit ].


This blog is made available by Foley & Lardner LLP ("Foley" or "the Firm") for informational purposes only. It is not intended to convey the legal position of the firm on behalf of a client, nor to provide specific legal advice. The opinions expressed in this article do not necessarily reflect those of Foley & Lardner LLP, its partners or customers. As a result, do not act on this information without seeking the advice of an authorized lawyer.
This blog is not meant to create, and the receipt of it does not constitute, a lawyer-client relationship. Communicating with Foley through this website via email, blog post or otherwise, does not create an attorney-client relationship for any legal matter. Therefore, any communication or material that you transmit to Foley through this blog, whether by email, blog or otherwise, will not be considered confidential or proprietary.
The information on this blog is published "IN THE STATE" and is not guaranteed to be complete, accurate and up-to-date. Foley makes no representations or warranties of any kind, express or implied, as to the operation or content of the site. Foley expressly disclaims all other warranties, warranties, conditions and representations of any kind, express or implied, arising from any law, law, commercial or other use, including any implied warranties of merchantability, fitness for a particular purpose particular, title and offense. In no event shall Foley or any of its partners, officers, employees, agents or affiliates be liable, directly or indirectly, under any theory of law (contract, tort, negligence or otherwise) , for you or any other person, for any claim, loss or damage, direct, indirect special, incidental, punitive or consequential, resulting or occasioned by the creation, use or trust on this site (including information and other content) or any third party website or the information, resources or materials accessed through these websites.
In some jurisdictions, the content of this blog may be considered an advertising advocate. If applicable, please note that previous results do not guarantee a similar result. The photographs are for dramatic purposes only and may include models. Similarities do not necessarily imply the current status of client, partnership or employee.


Leave a Reply